Efficacy and safety of garadacimab in patients with severe COVID-19

被引：1
|
作者：
Papi, A. [1 ]
Stapleton, R. [2 ]
Shore, P. M. [3 ]
Bica, M. A. [4 ]
Chen, Y. [5 ]
Larbig, M. [6 ]
Welte, T. [7 ]
机构：
[1] Univ Ferrara, Resp Dept, Ferrara, Italy
[2] Univ Vermont, Pulm & Crit Care Med, Burlington, VT USA
[3] CSL Behring, Clin Dev, King Of Prussia, PA USA
[4] CSL Behring Innovat, Global Clin Safety & Pharmacovigilance, Marburg, Germany
[5] CSL Behring, Biostat, King Of Prussia, PA USA
[6] CSL Behring AG, Clin Dev, Bern, Switzerland
[7] Hannover Med Sch, Dept Pulm & Infect Dis, Hannover, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2042
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2042
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19
    Alberto Papi
    Renee D. Stapleton
    Paul M. Shore
    Mihai Alexandru Bica
    Younan Chen
    Michael Larbig
    Tobias Welte
    Lung, 2023, 201 : 159 - 170
  • [2] Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19
    Papi, Alberto
    Stapleton, Renee D.
    Shore, Paul M.
    Bica, Mihai Alexandru
    Chen, Younan
    Larbig, Michael
    Welte, Tobias
    LUNG, 2023, 201 (02) : 159 - 170
  • [3] POPULATION PHARMACOKINETIC ANALYSIS OF GARADACIMAB IN SEVERE COVID-19 SUBJECTS.
    Sharma, A.
    Pawaskar, D.
    Glassman, F.
    Shore, P.
    Tarrant, J.
    Quazi, K.
    Roberts, A.
    Darby, B.
    McCal-Lum, H.
    Lichtfuss, M.
    Larbig, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S79 - S79
  • [4] Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19
    Abbasian, Ladan
    Toroghi, Negar
    Rahmani, Hamid
    Khalili, Hossein
    Hasannezhad, Malihe
    Ghiasvand, Fereshteh
    Jafari, Sirous
    Salehi, Mohammadreza
    Salahshour, Faeze
    Gorabi, Mahsa Azadbakhsh Kanaf
    Alizade, Fateme
    Ghaderkhani, Sara
    Nakhostin, Maryam
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 107
  • [5] The efficacy of probiotics in patients with severe COVID-19
    Wang, Huaqi
    Wang, Yunfei
    Lu, Chunya
    Qiu, Lingxiao
    Song, Xiangjin
    Jia, Hongxia
    Cui, Dong
    Zhang, Guojun
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (12) : 12374 - 12380
  • [6] Efficacy and safety of tocilizumab in COVID-19 patients
    Zheng, Kai-Lian
    Xu, Ying
    Guo, Yu-Feng
    Diao, Le
    Kong, Xiang-Yu
    Wan, Xiao-Jian
    Zhao, Feng
    Ning, Fang-Zheng
    Wang, Li-Bing
    Qiao, Fan
    Zhao, Jiang-Man
    Zhou, Jia-Huan
    Zhong, Yue-Qian
    Wu, Shou-Xin
    Chen, Yi
    Jin, Gang
    Dong, Yu-Chao
    AGING-US, 2020, 12 (19): : 18878 - 18888
  • [7] Efficacy and safety of molnupiravir for COVID-19 patients
    Fatima, Maurish
    Azeem, Saleha
    Saeed, Junaid
    Shahid, Abia
    Cheema, Huzaifa Ahmad
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 102 : 118 - 121
  • [8] Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
    Ameri, Ali
    Asadi, Masoomeh Frouz
    Ziaei, Ava
    Vatankhah, Majid
    Safa, Omid
    Kamali, Manoochehr
    Fathalipour, Mohammad
    Mahmoodi, Masoumeh
    Hassanipour, Soheil
    INFLAMMOPHARMACOLOGY, 2023, 31 (01) : 265 - 274
  • [9] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Li, Qiuyu
    Cui, Cheng
    Xu, Fei
    Zhao, Jianping
    Li, Nan
    Li, Haichao
    Wang, Tianbing
    Zhang, Hua
    Liu, Na
    Wei, Yudong
    Niu, Xiaoye
    Xu, Yan
    Dong, Jianping
    Yao, Xueting
    Wang, Xiaohong
    Chen, Yahong
    Li, Haiyan
    Song, Chunli
    Qiao, Jie
    Liu, Dongyang
    Shen, Ning
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (04) : 660 - 663
  • [10] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Qiuyu Li
    Cheng Cui
    Fei Xu
    Jianping Zhao
    Nan Li
    Haichao Li
    Tianbing Wang
    Hua Zhang
    Na Liu
    Yudong Wei
    Xiaoye Niu
    Yan Xu
    Jianping Dong
    Xueting Yao
    Xiaohong Wang
    Yahong Chen
    Haiyan Li
    Chunli Song
    Jie Qiao
    Dongyang Liu
    Ning Shen
    Science China(Life Sciences) , 2021, (04) : 660 - 663
12345